Cargando...
B-lymphocyte subpopulations in patients with rheumatoid arthritis and the effect of an interleukin-6 receptor inhibitor on them.
The clinical efficacy and safety of interleukin-6 (IL-6) receptor blockade have been well studied, but the data on the impact of therapeutic inhibition of IL-6 on B cells are scarce and contradictory. Preliminary reports have shown that B cell function and a humoral immune response may be modulated...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | Artigo |
Lenguaje: | Russo |
Publicado: |
IMA-PRESS LLC
2019-01-01
|
Colección: | Научно-практическая ревматология |
Materias: | |
Acceso en línea: | https://rsp.mediar-press.net/rsp/article/view/2650 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|